Keros Therapeutics (KROS)

Keros Therapeutics (KROS) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• KROS last traded at $9.13, -2.46% on the day.
• Keros Therapeutics: market cap $179.17M, revenue $40.76M over the last four quarters.
• Over the past year KROS returned -43.54%; year to date -55.16%.

Updated 2026-11-10 04:57 UTC